Caplight Directory>Investors>BioInnovation Institute>Bii


BioInnovation Institute

BioInnovation Institute

Copenhagen, Capital Region of Denmarkbii.dk

Overview

BioInnovation Institute (BII) is an international foundation that accelerates world-class life science innovation for the benefit of people and society. BII operates company creation programs and provides early-stage life science start-ups with knowledge, network, infrastructure, and funding. Its focus areas include human health (therapeutics, health tech), planetary health (bioindustrials), and societal resilience (deep tech, quantum science). Established by the Novo Nordisk Foundation, BII became an independent foundation in 2020 and provides funding through grants and convertible loans to help research-based ideas reach the market.

Portfolio Companies

25

Website

bii.dk

Investments

CompanyDateStageLead
Ibnova TherapeuticsMar 2026AcceleratorLead
MycoverseMar 2026Pre SeedCo-investor
CambioticsFeb 2026SeedCo-investor
Fuse VectorsFeb 2025Pre SeedCo-investor
LomaSep 2024Convertible DebtLead
View all investments

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersCopenhagen, Capital Region of Denmark
Year FoundedN/A

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.